Hepatitis B goes globe: Telbivudine as a new treatment option

Authors

  • Frank Tacke M.D., Ph.D.,

    1. Medical Clinic III, RWTH-University Hospital Aachen, Aachen, Germany
    Search for more papers by this author
    • Potential conflict of interest: Drs. Trautwein and Tacke received grants from Novartis, Bristol-Myers Squibb, and Gilead.

  • Christian Trautwein M.D.

    1. Medical Clinic III, RWTH-University Hospital Aachen, Aachen, Germany
    Search for more papers by this author
    • Potential conflict of interest: Drs. Trautwein and Tacke received grants from Novartis, Bristol-Myers Squibb, and Gilead.


No abstract is available for this article.

Ancillary